Evidence map›Paper›PMID 36936908›Full record

ArticleFrontiers in immunology2023

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.

Andrea R Daamen, Hongyang Wang, Prathyusha Bachali, Nan Shen, Kathryn M Kingsmore, Robert D Robl, Amrie C Grammer, Shu Man Fu, Peter E Lipsky

Open access · goldFull text read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Andrea R DaamenAMPEL BioSolutions LLC, Charlottesville, VA, United States.
Hongyang WangCenter for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.
Prathyusha BachaliAMPEL BioSolutions LLC, Charlottesville, VA, United States.
Nan ShenShanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Kathryn M KingsmoreAMPEL BioSolutions LLC, Charlottesville, VA, United States.
Robert D RoblAMPEL BioSolutions LLC, Charlottesville, VA, United States.
Amrie C GrammerAMPEL BioSolutions LLC, Charlottesville, VA, United States.
Shu Man FuCenter for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.
Peter E LipskyAMPEL BioSolutions LLC, Charlottesville, VA, United States.
Ampel BioSolutions (United States) · USUniversity of Virginia · USShanghai Jiao Tong University · CN

Funding

Cellular and Genetic Basis of Systemic LupusR01AR047988 · NIAMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FU, SHU MAN · 2001 to 2020
$8.4M
NLRP3 Inflammasome Activation, T Follicular Helper Cells and AutoimmunityR01AI148231 · NIAID · UNIVERSITY OF VIRGINIA · PI SUNG, SUN-SANG JOSEPH · 2020 to 2023
$2.5M
NIAID NIH HHS R01 AI148231NIAMS NIH HHS R01 AR047988
6 · The paper itself

Abstract

Introduction: Pathologic inflammation is a major driver of kidney damage in lupus nephritis (LN), but the immune mechanisms of disease progression and risk factors for end organ damage are poorly understood. Methods: To characterize molecular profiles through the development of LN, we carried out gene expression analysis of microdissected kidneys from lupus-prone NZM2328 mice. We examined male mice and the congenic NZM2328.R27 strain as a means to define mechanisms associated with resistance to chronic nephritis. Gene expression profiles in lupus mice were compared with those in human LN. Results: NZM2328 mice exhibited progress from acute to transitional and then to chronic glomerulonephritis (GN). Each stage manifested a unique molecular profile. Neither male mice nor R27 mice progressed past the acute GN stage, with the former exhibiting minimal immune infiltration and the latter enrichment of immunoregulatory gene signatures in conjunction with robust kidney tubule cell profiles indicative of resistance to cellular damage. The gene expression profiles of human LN were similar to those noted in the NZM2328 mouse suggesting comparable stages of LN progression. Conclusions: Overall, this work provides a comprehensive examination of the immune processes involved in progression of murine LN and thus contributes to our understanding of the risk factors for end-stage renal disease. In addition, this work presents a foundation for improved classification of LN and illustrates the applicability of murine models to identify the stages of human disease.

Indexed as

GlomerulonephritisKidney Failure, ChronicLupus NephritisAnimalsChronic DiseaseHumansInflammationKidneyMaleMicebioinformaticslupusmouse modelsnephritistranscriptomicstranslational

Identifiers

PMID36936908
PMCPMC10016352
OpenAlexW4322617967

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read22
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.